Wild-type human serotype 2 (Ad2) or serotype 5 (Ad5) adenoviruses naturally infect resting cells (e.g., epithelial cells), in which they induce a lytic productive cycle. Completion of the infectious cycle is primarily dependent on the expression of a set of viral regulatory proteins encoded by early transcription units, including early regions 1 (E1A and E1B) and 4 (E4), which subvert endogenous regulation mechanisms that are crucial for cell viability, viral DNA replication, and virus productivity. For example, E1A and E1B encode a class of oncogenic proteins that drive a quiescent cell into the S phase of the cell cycle (E1A), while escaping apoptosis (E1B), in particular through a coordinate targeting of the RB and p53 proteins (for a recent review, see reference 45) . E4 is another region that is essential for virus growth, as a result of its pleiotropic involvement in viral gene expression, DNA replication, and particle assembly (16, 23) . Located at the right end of the virus genome ( Fig. 1) , E4 encodes regulatory proteins that act throughout the infectious cycle. This is the case for the E4orf6/7 protein, which associates with endogenous DP-1/E2F transcription factors (2, 15, 24, 37) , transforming them into E2A-specific transactivators during the early phase of infection, thereby illustrating the pleiotropic involvement of E4 in the control of virus DNA replication (54, 55) and transcription (8, 62) . E4 is also required for the emergence and/or cytoplasmic accumulation of spliced mRNAs derived from the late primary transcript that encode most of the virion structural proteins (5, 23, 25) .
These posttranscriptional modifications are dependent upon an essential function shared by the E4orf3 and E4orf6 proteins (27) , which somehow regulates the extensive maturation of this 28-kb-long RNA molecule and/or the subsequent nuclear export of its corresponding mRNAs. Accordingly, in vitro data suggest that both Ad5 E4 proteins, directly or indirectly, modulate the splicing modalities within a human cell, including exon skipping and the recognition of distal splice acceptor sites (36) . The E4orf6 protein exhibits additional functions through its interaction with the E1B 55-kDa protein (20) , regulating export of viral and cellular mRNAs from the nucleus (1, 40, 43) . The E4orf6 protein has also been reported to interact with the C-terminal regulatory domain of the p53 tumor suppressor, inhibiting p53-dependent transactivation and apoptosis (13, 34) . Another E4 protein, the E4orf4 protein, apparently associates with endogeneous phosphatase 2A, modulating the function of viral (e.g., E1A) and cellular transcription factors (4, 28, 35) .
Drastically attenuated versions of Ad2 and Ad5 have been engineered following deletion of the E1A and E1B transcription units. As a consequence, these deletants do not propagate in most human cells except within artificial (packaging) cell lines that provide in trans the missing regulatory functions. Since 1993, E1-deleted recombinant viruses that contain a transgene expression cassette inserted in place of the E1 region have been evaluated in phase I clinical trials that target proliferative (e.g., cancer) or recessive deficiency (e.g., cystic fibrosis) disorders. Most (i.e., 80%) of the 36-kb viral genome is retained within these vectors, and the sole deletion of E1 cannot completely abrogate viral gene expression. For example, early (the 72-kDa E2A-encoded product) and late (the L3-encoded hexon and the L5-encoded fiber) proteins have been detected following administration of E1-deleted viruses in the liver (59), brain (7) , lung (14) , and muscle (10) tissues of permissive (cotton rat) and nonpermissive (e.g., murine) species. It has been proposed that de novo in vivo synthesis of viral proteins within the transduced cells elicits their major histocompatibility complex class I-restricted destruction by activated cytotoxic effectors (57) . The immune response to the virally infected cells accounts, at least in part, for the progressive loss of transgene expression observed following administration of recombinant adenoviruses to immunocompetent hosts (49, 58) . In view of these limitations, deletions that inactivate additional nondispensable regulatory genes have been incorporated within the backbone as recently described for the E2A and E4 genes (18, 21, 30, 53, 60) . Here we have compared the in vitro and in vivo behaviors of a set of isogenic E1-and E1/E4-defective adenoviruses with different E4 coding potentials.
MATERIALS AND METHODS
Cell lines. 293 is a human embryonic kidney cell line transformed by the E1A and E1B genes of Ad5 (22) . Hep3B is a human hepatocarcinoma cell line characterized by an integrated copy of the hepatitis B virus genome. Both cell lines were obtained from the European Collection of Animal Cell Cultures (Salisbury, United Kingdom). They were cultivated at 37°C in 5% CO 2 in minimum Eagle's medium (293 cells) or Dulbecco's modified Eagle medium (Hep3B cells) supplemented with 10% heat-inactivated fetal calf serum and nonessential amino acids. W162 is an E4-transcomplementing cell line of monkey origin permissive for E1 ϩ
E4
Ϫ human adenoviruses (56) . IGRP2 is an E1/E4-transcomplementing cell line that has been derived from 293. It was obtained following transformation of 293 cells with the plasmid pORF6Gen (60) , in which the distal (ORF6ϩORF7) moiety of Ad5 E4 is under control of the murine mammary tumor virus long terminal repeat (LTR). IGRP4 is similar to IGRP2 except that 293 cells were transfected with plasmid pE4Gen. This plasmid is identical to pORF6Gen except that it contains the entire Ad5 E4 locus (Ad5 nucleotides [nt] 32490 to 35576 [the numbering refers to the sequence under GenBank accession no. M73260]). IGRP2 and IGRP4 cells were cultivated like 293 cells except that 300 g of Geneticin (Sigma) per ml was added to the culture medium.
Recombinant adenoviruses. AdRSV␤Gal (48) is an E1-defective virus that expresses a nucleus-targeted ␤-galactosidase from the Rous sarcoma virus (RSV) LTR. In addition to a deletion of E1 (Ad5 nt 454 to 3328), AdRSV␤Gal exhibits a large deletion within E3 (Ad5 nt 28592 to 30470). AdE3ϩ␤Gal is identical to AdRSV␤Gal except that it contains a complete E3 locus. It was constructed in 293 cells by homologous recombination between the genome of Ad␤Gal/dl1011 (see below) and a plasmid containing the 3.15-kb right-end fragment of the Ad5 genome.
The construction of Ad␤Gal/dl1014 has been previously detailed (60) . Ad␤Gal/ dl1004, Ad␤Gal/dl1007, and Ad␤Gal/dl1011 were constructed in IGRP4 cells by combining the E1 deletion of AdRSV␤Gal with the E4 deletion of viruses H5dl1004, H5dl1007, and H5dl1011, respectively (5) . Viruses Ad␤Gal/dl1004 and Ad␤Gal/dl1007 were constructed by IGRP4 cells by cotransfection of an AseI-restricted AdRSV␤Gal genome with H5dl1004 or H5dl1007 NsiI-restricted DNA, respectively. Ad␤Gal/dl1011 was constructed by cotransfecting IGRP4 cells with linearized plasmid pRSV␤Gal (48) and ClaI-restricted H5dl1011 viral DNA. IGRP4 cells were transfected with 5 g of each partner DNA by the calcium phosphate technique (Ad␤Gal/dl1011) or with the Transfectam Reagent kit (Promega) (Ad␤Gal/dl1004 and Ad␤Gal/dl1007) and allowed to incubate in the presence of 1 M dexamethasone. Viral progeny was progressively amplified on IGRP4 cells supplemented with dexamethasone prior to plaque purification onto IGRP2 cell monolayers as described previously (60) . ␤-Galactosidase-expressing plaques were randomly picked and amplified on IGRP2 cells, and low-molecular-weight DNA was extracted (26) . Recombinant viruses with the expected restriction patterns were subjected to at least another round of plaque purification on IGRP2 cell monolayers and their clonality was assessed by Southern analyses and/or PCR amplification as described previously (60) .
Viral stock preparation. Viral stocks of Ad␤Gal/dl1004, Ad␤Gal/dl1007, Ad␤Gal/dl1011, and Ad␤Gal/dl1014 were prepared from viral particles purified from the culture medium of infected IGRP2 cells. Briefly, IGRP2 cells were infected at a multiplicity of infection (MOI) of 3 lacZ transduction units (TDU)/ cell (see below), and infection was allowed to proceed until complete detachment of the cell monolayer (i.e., 8 to 12 days postinfection [p.i.]). The culture medium was then harvested, clarified by depth filtration, and concentrated by ultrafiltration. Viruses were subsequently purified by step and isopycnic CsCl ultracentrifugations, desalted on PD10 columns (Pharmacia), and eluted in phosphatebuffered saline (PBS), before being aliquoted and stored at Ϫ70°C in PBS-10% glycerol. Viral stocks of AdRSV␤Gal and AdE3ϩ␤Gal were prepared from infected 293 cells as described above or from intracellular lysates by standard procedures (48) .
All viral stocks were titrated on W162 monolayers as TDU, a unit that corresponds to the number of ␤-galactosidase-positive cells counted after 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) staining at 48 h p.i. (60) . W162 cells were chosen as indicator cells for titration essentially because there is no endogeneous ␤-galactosidase background activity in these cells. Viral stocks with similar titers were recovered for all viruses used in this study. After the purification process, this translated into a productivity that ranged from 15 (Ad␤Gal/ dl1011) to 60 (Ad␤Gal/dl1014) TDU/cell, compared to 100 TDU/cell for AdE3ϩ ␤Gal. All viral stocks were tested for the presence of replication-competent adenoviruses by using a quantitative assay that detects one replication-competent adenovirus within 10 8 TDU (52) . Stocks of AdE3ϩ␤Gal were negative for doses of 10 7 TDU, and all stocks of the doubly E1/E4-defective viruses were negative for the tested doses (ranging from 2 ϫ 10 8 to 5.4 ϫ 10 8 TDU). Isolation of viral DNA for slot blot and Southern analyses. Hep3B cells grown in six-well dishes were infected at an MOI of 20 TDU/cell, and low-molecularweight DNA (26) was prepared at different times p.i. Infection controls were systematically included in parallel experiments by counting the number of X-Galpositive cells at 48 h p.i. Also, a given number of TDU translated into identical amounts of intracellular virus DNA 6 h after infection with any of the E1-or E1/E4-defective recombinant viruses (this report). Undiluted (one-fifth of the preparation) and diluted (10-fold serial dilutions) samples were denatured and applied under vacuum to positively charged polyamine membranes (Nytran-plus; Schleicher & Schuell) by using a Minifold I slot blot apparatus according to the instructions of the manufacturer (Schleicher & Schuell). The membranes were prehybridized for 1 h at 65°C in 0.25 M NaH 2 PO 4 -0.25 M Na 2 HPO 4 -7% sodium dodecyl sulfate (SDS). Virus-specific DNA was detected following hybridization of the membrane in the same buffer overnight at 65°C with an Ad5 fragment (pIX and IVa2 regions, nt 3494 to 6314) that was labelled with [␣-32 P]dCTP by the random primer extension method (Megaprime kit; Amersham). The membranes were washed four times for 5 min each at room temperature in 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS and then for 10 min at 65°C in 1ϫ SSC-0.1% SDS and twice at 65°C for 10 min in 0.1ϫ SSC-0.1% SDS. Dried membranes were exposed to Fuji RX films with intensifying screens (Hyperscreen; Amersham). For Southern analyses, samples corresponding to one-fifth of the DNA preparations were digested with NdeI and run on a 0.8% agarose gel. The fragments were transferred to Nytran-plus membranes and hybridized to an [␣- 32 RNA isolation and Northern analyses. Subconfluent Hep3B cell monolayers were infected in 100-mm-diameter petri dishes at an MOI of 20 TDU/cell, and poly(A) ϩ RNAs were extracted at different times p.i. Again, infection controls were systematically included by counting the number of cells that scored positive following X-Gal staining. Also, to ensure maximum homogeneity among the RNA samples, all RNA preparations to be compared were carried out in parallel. Total cellular RNA was prepared from uninfected and infected cells by phenol extraction at low pH as described previously (47) . Poly(A) ϩ RNAs were isolated by using oligo(dT) columns according to the instructions of the supplier (Life Technologies). One to 2.5 g of poly(A)
ϩ RNA was denatured in formamide and formaldehyde and electrophoresed in 1ϫ MOPS (morpholinepropanesulfonic acid) buffer through 1% agarose-0.66 M formaldehyde gels as described previously (17) . They were capillary blotted to a nylon membrane (Hybond-N; Amersham) for 8 h and baked for 2 h at 80°C. [␣-
32 P]CTP-labelled antisense RNA probes specific for E2A, L3, and L5 transcripts were synthesized by in vitro transcription of appropriate Ad5 inserts cloned into the pBluescript phagemid (Stratagene) or pGEM vectors (Promega). The E2A antisense probe encompasses Ad5 nt 21562 to 23914 (the main body of E2A mRNAs is located between nt 22375 and 24041). The L3 antisense probe encompasses Ad5 nt 18319 to 21567 and thus hybridized to the pVI and hexon mRNAs, as their main bodies extend from nt 18002 to 22396 and nt 18806 to 22396, respectively. The L5 antisense probe encompasses Ad5 nt 31509 to 33594 (the main body of the L5 [encoding fiber] mRNA extends from nt 31042 to 32807). An actin-specific probe was systematically included as a loading and transfer control. It was prepared from a 1.5-kb mouse ␤-actin cDNA insert (32) cloned into pBluescript. In vitro transcription reactions, prehybridization, hybridization, and washing of the membranes were carried out as recommended by the supplier (Promega). Filters were exposed to Fuji RX films with intensifying screens (Hyperscreen; Amersham).
Immunoprecipitation of adenovirus hexon protein. Subconfluent Hep3B cells grown in 35-mm-diameter petri dishes were mock infected or infected with AdE3ϩ␤Gal or Ad␤Gal/dl1007 at an MOI of 20 TDU/cell. At various times p.i., cells were washed twice in PBS and labelled for 24 h in 90% methionine-free minimal essential medium-10% minimal essential medium containing 100 Ci/of [ 35 S]-methionine (1 Ci/mol; New England Nuclear) per ml. The cells were then washed twice in PBS and lysed in radioimmunoprecipitation assay buffer containing aprotinin and phenylmethylsulfonyl fluoride. Equal amounts, as assessed by trichloroacetic acid-precipitable radioactivity, were subjected to immunoprecipitation with 1:10-diluted antihexon antibody (AB 1056; Chemicon) and electrophoresed on SDS-6% polyacrylamide gels. The gels were subjected to fluorography (Amplify; Amersham), dried, and exposed to films with intensifying screens.
Quantification of ␤-galactosidase activity. Triplicates of subconfluent monolayers of Hep3B cells grown in six-well dishes were infected at an MOI of 20 TDU/cell and allowed to incubate in the absence or presence of cytosine-␤-Darabinofuranoside (araC). araC was added to a final concentration of 50 g/ml at the time of infection and every 24 h. Cells were harvested by trypsinization, washed twice in PBS, resuspended in lysis buffer (100 mM potassium phosphate [pH 7.8], 1 mM dithiothreitol), and subjected to six cycles of freezing and thawing. Cell debris were removed by centrifugation, and ␤-galactosidase activity in the supernatant was measured by a chemiluminescence assay (Clontech, Palo Alto, Calif.). Light emission was recorded as a 5-s integral with a Lumat LB9501 luminometer (Berthold, Bad Wildbad, Germany). The protein concentration in the cellular extract was determined with the Bio-Rad protein assay. Viral DNA accumulation was monitored on control wells as described above.
Mice. C57BL/6 mice (H-2 b ) were obtained from the IFFA Credo (Lyon, France). C57BL/6 lacZ-transgenic mice (TG mice) contain the lacZ gene under the control of the 5Ј regulatory sequence of the ␤ 2 -microglobulin gene (9) . They were obtained from the Centre de Développement des Techniques Avancées pour l'Experimentation Animale (Orleans, France) following at least 10 consecutive backcrosses with C57BL/6 mice. C57BL/6 immunodeficient mice (C57BL/6 nu mice) were obtained from Bomholtgard Ltd. (Ry, Denmark). They were obtained following four backcrosses of nu/nu mice onto a C57BL/6 genetic background. Adenovirus-mediated gene transfer to the liver was carried out after tail vein injection of 2.5 ϫ 10 9 to 5.1 ϫ 10 9 TDU of virus in 200 l of PBS-10% glycerol. All animal experiments were done in accordance with guidelines from the French Council of Animal Care and Testing.
Histological analyses. Liver samples were fixed in 4% paraformaldehyde for 3 h at 4°C. For morphometric analysis of lacZ expression, fixed liver sections were rinsed in PBS, permeabilized with 0.01% (wt/vol) sodium deoxycholate-0.2% (vol/vol) Nonidet P-40 in PBS-MgCl 2 , and incubated with 3 mM K 4 Fe (CN)6-3 mM K 3 Fe(CN) 6 -X-Gal in PBS for 4 h at 37°C. Data were quantified by analyzing 10 sections of each infected liver, representing a total of approximately 1,000 hepatocytes. A scoring system for grading virus-induced hepatic inflammation and necrosis from 5-m paraffin sections stained with hematoxylin and eosin was developed. Liver sections from noninfected animals were graded 0. Inflammation was graded 1 and referred to as minimal when it was characterized by an increased number of intravascular hematopoietic cells competent in immunity and/or inflammation, i.e., lymphocytes and rare neutrophil granulocytes. In grade 2, inflammation was characterized as mild: it was associated with the presence of few small intraparenchymatous lymphocyte foci (typically fewer than 10 per field at a magnification of ϫ200). Many more (typically 10 to 60 per field at a magnification of ϫ200) small foci were detected in grade 3 (marked inflammation). The foci were numerous and much larger in grade 4, and they contained numerous plasma cells. Grade 4 refers to inflammation characterized as severe, and it was observed only in the livers of nontransgenic animals infused with the E1-deleted recombinant virus (see Results). Necrosis was referred to as minimal (grade 1) when rare necrotic cells were apparent at the vicinity of the inflammatory foci. Necrosis was characterized as moderate (grade 2) when a few necrotic cells were apparent throughout the liver (i.e., even at sites distant from the inflammatory foci). Occurrence of multicellular necrotic foci indicated a marked necrosis (grade 3). Grade 4 indicated the presence of large patches of necrotic tissues (severe necrosis). With this scoring system, independent examinations of a given slide led to identical results.
Extraction of DNA from liver extracts for slot blot and Southern analyses. Liver fragments were frozen in liquid nitrogen, minced, and incubated overnight in SDS-proteinase K buffer. DNA was prepared following one phenol, two phenol-chloroform, and two chloroform extractions prior to ethanol precipitation and resuspension in water-RNase A (5 g/ml). For Southern analyses, 20 g of DNA was digested with SalI or NotI prior to electrophoresis in a 0.7% agarose gel run in Tris-acetate-EDTA. The gel was blotted in 0.4 N NaOH onto a Hybond-Nϩ nylon membrane (Amersham Life Sciences) for 18 h. The filter was washed briefly in 2ϫ SSC and baked at 80°C for 2 h. The membrane was prehybridized for 1 h at 65°C in 5ϫ SSC-5ϫ Denhardt's solution-0.5% SDS-100 g of salmon sperm DNA per ml, followed by overnight hybridization at 65°C in the same buffer. It was then washed twice at room temperature in 2ϫ SSC-0.1% SDS for 10 min, once in 1ϫ SSC-0.1% SDS at 65°C for 15 min, and twice in 0.1ϫ SSC-0.1% SDS for 10 min, prior to exposure to Fuji RX film at Ϫ80°C with an intensifying screen. The probe corresponded to AdRSV␤Gal NotI-digested DNA that was randomly labelled with [␣-
32 P]dCTP. For slot blot analyses, 10 g of DNA was heated in 0.4 M NaOH-2.2 mM EDTA at 95°C for 2 min and transferred to a Hybond-Nϩ nylon membrane. DNA was fixed by baking the membrane at 80°C for 2 h. Hybridization was carried out as described above. A second hybridization with a single-copy murine gene consisting of a 1.5-kb EcoRI-XhoI fragment from the mouse ␤-actin cDNA (Stratagene) was used as a loading control for standardization. Membranes were exposed to Fuji Imaging Plates (type BAS-IIIS) and analyzed with a Fujix Bas 1000 phosphorimager with the MacBAS version 2.2 program (Fuji Photo Film Co.). In a given quantification experiment, variability was within a 15% range.
RESULTS
Virus construction and titration. Five recombinant adenoviruses were constructed and used in this study (see Materials and Methods). AdE3ϩ␤Gal is an E1-defective recombinant adenovirus, while Ad␤Gal/dl1004, Ad␤Gal/dl1007, Ad␤Gal/ dl1011, and Ad␤Gal/dl1014 exhibit an additional deletion in the E4 locus that renders them doubly defective for growth. All of the recombinant adenoviruses exhibit a complete E3 locus, carry the same ␤-galactosidase expression cassette inserted in place of E1 (48) , and are strictly identical except for the status of their E4 regulatory locus (5) . DNA sequencing confirmed that deletions extended from position 33094 to 35052 (dl1004), 33467 to 35355 (dl1007), and 33094 to 35355 (dl1011). The deletion of Ad␤Gal/dl1014 has been assessed previously (60) . Accordingly, Ad␤Gal/dl1004 (ORF1ϩ) and Ad␤Gal/dl1014 (ORF4ϩ) retain the potential to express the E4orf1 and E4orf4 proteins, respectively, from the E1A-responsive E4 promoter. In contrast, Ad␤Gal/dl1007 and Ad␤Gal/dl1011 exhibit larger deletions which abrogate synthesis of all E4-encoded gene products (Fig. 1) .
Concentrated purified stocks of the E1-and E1/E4-defective recombinant viruses were prepared, and the clonality of each virus was demonstrated by restriction analysis, Southern blotting, and/or PCR amplification of the viral DNA (data not shown). Because comparison of the titers of E1-and E1/E4-defective viruses on the basis of PFU is only marginally relevant due to the use of indicator cell lines with different plaquing efficiencies, titers were expressed as TDU within W162 cells. The E4-positive status of the W162 indicator cell line does not introduce any bias when E4-competent or E4-defective viruses are titrated, because transduction titers were identical following infection of its E4-defective parental cell line (Vero). The titers of the AdRSV␤Gal or AdE3ϩ␤Gal virus expressed as PFU on 293-derived monolayers are roughly twice those determined as TDU in W162 cells.
Replication of virus DNA in nonpermissive cells of human origin.
We first compared the abilities of different tumor-derived cell lines of human origin (Hep3B, HeLa, KB, and HepG2) to sustain viral DNA accumulation following infection with an E1-deleted virus. A quantitative slot blot assay was used for this comparison; low-molecular-weight DNA was extracted (26) at different times p.i. and hybridized with an Ad5-specific radiolabelled probe (see Materials and Methods). A typical slot blot analysis carried out on Hep3B cells is shown in Fig. 2A . Upon AdE3ϩ␤Gal infection at an MOI of 20 TDU/ cell, a significant increase in the amount of viral DNA was detected as early as 48 h p.i. and peaked at 72 h to more than 30-fold the initial amount. AdE3ϩ␤Gal DNA levels did not increase beyond 72 h p.i., very likely because extensive cell damage occurred as early as 3 days p.i. and led to cell detachment (see below). The quantity of viral DNA initially applied to the cells was less than twofold higher than that detected at 6 h p.i., indicating that the 30-fold increase of AdE3ϩ␤Gal DNA that occurred following infection did reflect some kind of replication. This conclusion was further supported by the absence of viral DNA accumulation when araC, a known inhibitor of adenovirus DNA replication, was included in the culture medium (see Fig. 7A ). In contrast with the case for AdE3ϩ ␤Gal, infection with any of the E1/E4-defective viruses under identical conditions (20 TDU/cell) showed no or very little increase of intracellular viral DNA over a period of 4 days p.i. Note that the cells had been similarly infected with the E1-or E1/E4-defective viruses as demonstrated by similar amounts of viral DNA at 6 h p.i. (Fig. 2A) , together with a similar number of lacZ-expressing cells following infection (see Fig. 6 ). DNA extracts were also subjected to NdeI restriction and Southern analyses with an AdRSV␤Gal-specific radiolabelled probe.
Typical results are shown in Fig. 2B for AdE3ϩ␤Gal and Ad␤Gal/dl1007 over a period of 4 days p.i. Notably, restriction patterns confirmed the identity of the infecting viruses and that the cells had been similarly infected. Again, an important increase was apparent 2 days p.i. with AdE3ϩ␤Gal DNA but not with the E1/E4-defective virus. The results also indicate a stoichiometric proportion of the restriction fragments, indicating that replication of AdE3ϩ␤Gal DNA resulted not from abortive cycles but rather from a bona fide replication of full-length genomes. Densitometric quantifications of the restriction fragments indicated levels of Ad␤Gal/dl1007 DNA that were roughly 20-to 30-fold lower than those of AdE3ϩ␤Gal at 4 days p.i., in good agreement with the quantification of the slot blots.
Comparison of early and late viral gene expression. Adenovirus DNA replication is dependent upon the E2A-encoded 72-kDa DNA binding protein (50) . We have used Northern blot analysis to compare the levels of E2A mRNA in cells infected with AdE3ϩ␤Gal or the doubly defective viruses. As a loading and transfer control for all Northern blotting experiments in this study, membranes were systematically hybridized to a radiolabelled probe specific to the ␤-actin mRNA, as its steadystate level is not greatly affected by infection with an E4-competent or an E4-defective adenovirus (42) . As shown in Fig. 3 , Hep3B cells exhibited higher levels of E2A-specific RNAs at 48 h p.i. with the E4-competent virus (compare lane 2 with lanes 3 to 6), in agreement with the larger amount of AdE3ϩ ␤Gal DNA detected at this time (Fig. 2) . Again, there was no significant difference between the doubly E1/E4-defective viruses that were tested, including Ad␤Gal/dl1014, which exhibits a deletion within E4 that is associated, in the presence of an intact E1 region, with a severe impairment of DNA replication in HeLa cells (6) . We next assessed the consequences for late gene expression that were associated with the deletion of E4 sequences from the backbone. L3 (pVI and hexon)-and L5 (fiber)-specific RNAs were analyzed by Northern blotting of poly(A) ϩ RNAs from Hep3B cells infected at an MOI of 20 TDU/cell. Infection with the AdE3ϩ␤Gal virus was associated with significant levels of pVI (4.6-kb) and hexon (3.8-kb) L3 mRNAs at 48 h p.i. (Fig. 4A, lane 2) . In contrast, these species were not detected when the cells were infected with any of the E1/E4-defective viruses (Fig. 4A, lanes 3 to 6) . Exposure of the film for 60 h instead of 6 h was required to detect faint signals that corresponded to these late mRNAs (data not shown). When the same RNA preparations were hybridized to a probe specific for the 2.5-kb fiber-encoding mRNA (L5), similar differences were evident depending on the presence or absence of a functional E4 region within the viral backbone: fiber-specific poly(A) ϩ RNAs were unambiguously detected in AdE3ϩ␤Gal-infected cell extracts (Fig. 4B, lane 2) but not when the E1/E4-defective viruses were used (lanes 3 to 6), even after longer exposures of the film. Immunoprecipitation experiments also demonstrated hexon protein synthesis as early as 2 days p.i. with the E1-deleted virus, but not the doubly defective virus, even after 6 days (Fig. 5) .
Phenotypic consequences of viral infection. A remarkable feature that emerged during the course of this study is that infection of nonpermissive cells with an E1-or an E1/E4-defective virus was associated under our experimental conditions with different outcomes with regard to cell morphology and survival. For example, infection of Hep3B cells with AdE3ϩ␤Gal at an MOI of 20 TDU/cell resulted in phenotypic abnormalities as early as 3 days p.i.: a large number of cells had detached from their support, while most of the remaining cells exhibited evidence of cell enlargement, rounding, and clumping (Fig 6D) . These cellular abnormalities were also observed following infection with another E1-deleted adenovirus (AdRSV/␤Gal) and no matter what process was used to prepare the stocks (see Materials and Methods). In contrast, there was no apparent virus-induced cytotoxicity following infection with Ad␤Gal/dl1007 (20 TDU/cell, corresponding to the same number of lacZ-expressing cells at 48 h p.i.) (compare Fig. 6A and B). Four days after infection, i.e., at a time when AdE3ϩ ␤Gal-infected cells were almost completely detached (Fig.  6G) , Ad␤Gal/dl1007-infected cells appeared to be as healthy as their mock-infected counterparts. This was also true 5 days after infection (compare Fig. 6F and H) , after which both mock-and Ad␤Gal/dl1007-infected cell monolayers started to exhibit signs of cell deterioration. Again, Ad␤Gal/dl1004, Ad␤Gal/dl1011, and Ad␤Gal/dl1014 behaved similarly to Ad␤Gal/dl1007 in this assay.
Quantitative analysis of lacZ expression in vitro. A quantitative ␤-galactosidase assay was used to compare the abilities of AdE3ϩ␤Gal and E1/E4-defective viruses to express their transgene following infection. Experiments were carried out in the presence of araC to prevent any bias resulting from different levels of viral DNA accumulation following infection with either type of virus. Under the conditions used (20 TDU/cell in the presence of 50 g of araC per ml), there was no increase of viral DNA in infected Hep3B cells during the entire time course of the experiment (Fig. 7A) , and this translated into kinetics and levels of ␤-galactosidase specific activity that were not significantly different following infection with AdE3ϩ␤Gal or Ad␤Gal/dl1007 (Fig. 7B) .
Assessment of the lacZ-transgenic mouse model. The relative importance of the transgene versus viral proteins in the immune clearance of the virally infected cells in mice is a complex issue that has led to different conclusions with different strains of mice (49, 58) . We have addressed this issue with C57BL/6 mice, a genetic background particularly responsive to adenovirus infections (19) . As a prerequisite, we assessed the relevance of a lacZ-transgenic line (9) with a C57BL/6 genetic background to compare our lacZ recombinant adenoviruses. We first verified that there was no detectable expression of the lacZ transgene in the livers of noninfected adults and that systemic administration of a non-lacZ E1-defective recombinant adenovirus did not upregulate expression of the endoge- 1 and 2) or Ad␤Gal/dl1007 (lanes 5 to 9) at an MOI of 20 TDU/cell were labelled at the indicated times p.i. with [ 35 S]methionine for 24 h and extracted with radioimmunoprecipitation assay buffer. Equal amounts, as assessed by trichloroacetic acid-precipitable radioactivity, were subjected to immunoprecipitation with an antihexon antibody and analyzed on an SDS-6% polyacrylamide gel, except for lanes 3 and 10, for which 2.5 times less material was loaded. Labelling was initiated at the following times p. nous lacZ gene (data not shown). Next, 2.5 ϫ 10 9 TDU of AdE3ϩ␤Gal was infused via the tail veins of C57BL/6 mice and C57BL/6 lacZ-transgenic mice (TG mice), and the number of X-Gal-positive hepatocytes was monitored by histochemical staining ( Table 1) . Infusion of the virus led to drastic differences in the persistence of ␤galactosidase-positive hepatocytes in the two strains of mice. In the nontransgenic mice, the numbers dropped from 80 to 8% over a 24-day period and there were almost no remaining X-Gal-positive hepatocytes at day 45 p.i. In contrast, 50 and 33% of hepatocytes from the TG mice still scored positive at 24 and 45 days p.i., respectively.
To assess the extent of virus-induced inflammation and necrosis that developed within the liver, we have developed a reproducible scoring system (see Materials and Methods). The virus-induced inflammatory response of normal C57BL/6 mice was scored as minimal (grade 1) 4 days p.i., whereas multiple large intraparenchymatous lymphocyte foci that were associated with plasmocytes were apparent at day 24 p.i. (see Fig.  9A ). Inflammation was scored severe (grade 4) (Fig. 8C) at this time and then gradually decreased to grade 2 between days 24 and 66 p.i. The overall response of the TG mice to AdE3ϩ ␤Gal infection was significantly reduced: while the reaction of the non-TG mice was severe (grade 4) at day 24 p.i., that of the TG mice was scored as only mild (grade 2) (compare Fig. 8C and D; see also Fig. 9A ). At day 45, inflammation was also significantly reduced in the transgenic animals (Fig. 9A) , and it was minimal at day 66 p.i. (Fig. 9A) . The fact that inflammation triggered by an E1-deleted lacZ-encoding virus was reduced from severe (grade 4) to mild (grade 2) in the TG animals implicates the immune status of the host with regard to the Escherichia coli protein as a major determinant of the disappearance of the transduced hepatocytes in the C57BL/6 genetic background. The fact that the decreases of the X-Galpositive hepatocytes between 4 and 24 days p.i. were very similar when AdE3ϩ␤Gal was injected into C57BL/6 nude mice or the TG mice (Table 1) further supports this conclusion.
The additional inactivation of E4 allows long-term gene delivery in mouse liver. The TG mice were therefore used as a model to assess the behavior of lacZ-expressing E1-or E1/E4-defective recombinants in the liver. TG mice were infused with Ad␤Gal/dl1007 (4.6 ϫ 10 9 TDU) or AdE3ϩ␤Gal (2.5 ϫ 10 9 TDU) via the tail vein, as these doses were previously shown by X-Gal staining to transduce identical proportions of hepatocytes (75 to 80%) at 4 days p.i. Total cellular DNA from infected liver extracts was prepared and analyzed by slot blot and Southern analyses. Quantification of the viral DNA within the liver extracts indicated similar amounts 4 days after infection with either virus. Persistence of AdE3ϩ␤Gal DNA in the livers of the TG mice declined in a manner similar to that of the B-galactosidase-positive hepatocytes: 51, 26, and 14% of the amount of DNA at day 4 p.i. were detected 24, 45, and 88 days p.i., respectively (Fig. 10A) . In contrast, Ad␤Gal/dl1007 DNA was very stable, as 76% of the amount at day 4 p.i. was still present at day 88 p.i. Southern blotting of NotI-or SalI-restricted low-molecular-weight DNA from the infected liver confirmed the identity of the infecting virus. Furthermore, viral DNA was extrachromosomal, and it was not circularized or fragmented (Fig. 10B) . Because the enzymes used are inhibited by methylation of CpG dinucleotides, we also concluded that none of the NotI and SalI sites in the vector backbone were methylated, including those present in the RSV LTR. Despite the remarkable persistence of Ad␤Gal/dl1007 DNA in the liver, the number of X-Gal-positive hepatocytes dramatically decreased to 3.5% by day 24 and remained below 1% thereafter (Table 2) . For AdE3ϩ␤Gal and Ad␤Gal/dl1007, the kinetics of ␤-galactosidase specific activity (units per milligram of liver extract) was identical to that of the X-Gal-positive hepatocytes (data not shown). The rapid loss of transgene expression that followed injection of Ad␤Gal/dl1007 into TG mice was not restricted to the extent of the E4 deletion harbored by this particular doubly E1/E4-defective virus. Indeed, transgene expression had almost reached background levels 24 days after administration of Ad␤Gal/dl1004 or Ad␤Gal/dl1014 (Table 2) , although the viral DNA was still present (data not shown). Compared to the case for the E1-deleted control virus, infusion of the doubly defective adenoviruses into the TG mice promoted little (if any) inflammation (Fig. 9B) and necrosis (Fig. 9C) . For Ad␤Gal/dl1004, inflammation at day 24 p.i. was scored as mild for two of three animals (Fig. 9B) . Interestingly, the mild inflammation that was observed in these two animals was also correlated with a higher fraction of X-Gal-positive hepatocytes (7%).
DISCUSSION
We have assessed the consequences of inactivating E4 from virus AdE3ϩ␤Gal, an E1-deleted virus expressing a nucleustargeted B-galactosidase from the RSV LTR. The structural and functional complexities of the E4 regulatory locus prompted us to study a set of isogenic viruses (Ad␤Gal/dl1004, Ad␤Gal/dl1007, Ad␤Gal/dl1011, and Ad␤Gal/dl1014) lacking both E4orf3 and E4orf6 but otherwise retaining various coding potentials from the E1A-inducible E4 promoter (Fig. 1) . The recombinant adenoviruses were first compared in vitro under identical infection conditions. Compared to the E1-deleted control virus, infection with the doubly defective adenoviruses was associated in Hep3B cells with an impaired ability to replicate and express the viral genome, together with the extinction of virus-induced cytopathic effects. On the other hand, specific expression of the transgene was quantitatively unchanged in a short-term assay. As far as we can tell, all four E1/E4-defective viruses behaved identically, including Ad␤Gal/dl1014 (E4orf4 ϩ ), which exhibits a deletion that has been shown to inhibit viral DNA replication in HeLa cells (6) . This unexpected observation may result from the use of a different indicator cell line or because our construct also has a deletion within E1.
Our in vitro data truly reflect the additional consequences of inactivating the E4 function per se, because identical amounts of infectious viruses were used and led to (i) comparable transductions (Fig. 6 ) and (ii) similar intracellular amounts of viral DNA at 6 hours p.i. (Fig. 2) . The lower replication of viral FIG. 8 . Histological analysis of liver sections of mice injected with AdE3ϩ␤Gal. AdE3ϩ␤Gal (2.5 ϫ 10 9 TDU) was injected via the tail vein, and mice were sacrificed at day 4 (A and B) or 25 (C and D) p.i. Livers were fixed in 4% paraformaldehyde and stained for evaluation of ␤-galactosidase activity. By day 4, C57BL/6 (A) and TG (B) mouse livers exhibited the same proportion of ␤-galactosidase-positive cells (75 to 80%), while infection with a non-lacZ-encoding adenovirus led to X-Gal-negative hepatocytes (not shown). Liver histology (hematoxylin and eosin staining) was also assessed for each sample. A typical representation of the virus-induced inflammation is shown at day 25 p.i. A massive intraparenchymatous lymphocyte infiltration, which nearly subsided by day 66 p.i., is observed in C57BL/6 mice (C). Small foci scattered throughout the liver are observed following infection of TG mice (D).
DNA in cells infected with a doubly defective virus was in accordance with lower levels of E2A RNAs (Fig. 3) and protein (72-kDa DNA binding protein) as assessed by specific immunoprecipitation experiments (11) . Because E2A expression is dependent upon two pathways controlled by early regions 1A (E1A) and 4 (E4orf6/7) and because to our knowledge there is no evidence of a cellular activity that could substitute for E4orf6/7, expression of E2A following Hep3B infection with a virus lacking both functions is most likely the consequence of endogenous E1A-substituting factors of viral (44) and/or cellular (46) origin. Similar E1A-substituting activities may be widely present in human cells, as AdE3ϩ␤Gal DNA accumulated in all tested tumor-derived cell lines, including HepG2 (liver), HeLa (cervix), and KB (upper digestive tract) cells: a 25 (HeLa and KB)-to 60 (HepG2)-fold increase was observed between 3 and 4 days p.i. at an MOI that transduced between 70 and 90% of the cells. At a time when AdE3ϩ␤Gal DNA had reached its peak level, infection with the doubly defective adenoviruses led to a 3 (HeLa and KB)-to 15 (Hep3B and HepG2)-fold reduction of the viral genomes.
Dual inactivation of E4orf3 and E4orf6 directly or indirectly hampers the cytoplasmic accumulation of late adenovirus mRNAs (5, 23, 25) . We did not find evidence that an endogenous activity could efficiently substitute for this adenovirus regulatory activity. Indeed, infection of Hep3B cells with a doubly defective virus resulted in an almost complete shutdown in the steady-state levels of L3 (pVI-and hexon-encoding) and L5 (fiber-encoding) poly(A) ϩ RNAs at 48 h p.i. as compared to those observed when AdE3ϩ␤Gal was used (Fig. 4) . Reduction of late gene expression also occurred at the protein level as shown for the L3-encoded hexon protein (Fig. 5) . AdE3ϩ ␤Gal infection was also associated with the development of morphological alterations that ultimately led to cell death (Fig.  6 ). In contrast, no cytotoxicity was observed when identical doses of doubly defective viruses were used. In vivo detrimen- Table 2 for the injected doses and the percentages of lacZ-positive hepatocytes at the indicated times p.i. Typical grade 4 and grade 2 inflammations are illustrated in Fig. 8C and D, respectively. tal effects on cell viability that could result from the sole deletion of E1 from the adenovirus backbone may represent adjuvant side effects for cytotoxic antitumoral gene therapy approaches. On the other hand, the E4orf6 protein has been reported to inhibit the transactivation activity of p53 in vitro (13), a function required for its tumor-suppressing activity (61) . A direct (cytotoxic) or indirect (e.g., cytotoxic-T-lymphocyte-mediated) clearance of the infected cells that would result from the accumulation of viral proteins is also certainly not optimal for treatment of genetic deficiency disorders (e.g., cystic fibrosis), for which a conservative approach is needed. At least in this respect, the additional inactivation of E4 from the vector backbone may prove beneficial.
The murine response to recombinant adenoviruses is a complex event that hampers long-term survival of the transduced cells. Barr et al. (3) have reported a remarkable variability in the persistance of transgene expression, ranging from several weeks to more than 3 months when an E1-deleted adenovirus expressing human ␣-antitrypsin was infused into different inbred strains of mice. In another study, human erythropoietin expressed from an E1-deleted recombinant adenovirus injected intramuscularly was recognized as immunogenic, thereby limiting the efficacy of gene delivery in CD1-mice (49) . Another study using lacZ-transgenic mice (ROSA-26) injected with an E1-deleted lacZ recombinant adenovirus led to the conclusion that cytotoxic T lymphocytes specific to viral antigens were mostly responsible for the clearance of the transduced cells in vivo, while those directed against the E. coli ␤-galactosidase played a minor role (58) . The behaviors of the recombinant adenoviruses in this study have been compared in the livers of C57BL/6 mice, a genetic background which responds to adenovirus infection by mounting a strong, biphasic, cellular infiltration (19) . As a prerequisite, we have identified a C57BL/6 lacZ-transgenic line in which AdE3ϩ␤Gal-infected hepatocytes persisted in a manner similar to that in nu/nu mice backcrossed in the same genetic background (Table 1) . Based on the results of our in vitro study, we anticipated that E1-and E1/E4-defective adenoviruses would exhibit different behaviors in the livers of these model animals. This proved to be the case, as the additional deletion of E4 promoted the persistence of the viral chromosome for at least 3 months in the liver (Fig.  10A ). Molecular characterization demonstrated that viral DNA was extrachromosomal, linear, and nonmethylated (Fig.  10B) . 9 TDU) or Ad␤Gal/ dl1007 (4.6 ϫ 10 9 TDU) virus was administered to TG mice via tail vein injection. (A) At the indicated times p.i., the animals were sacrificed to quantify the viral DNA in the liver by a slot blot assay. Three animals were injected for each time point, except for Ad␤Gal/dl1007-infected mice at days 24, 45, and 88 p.i. (n ϭ 2). The mean value and its standard deviation are shown. The quantity of Ad␤Gal/ dl1007 DNA at day 4 p.i. was slightly higher than that of AdE3ϩ␤Gal DNA (ratio ϭ 1.13); it was normalized to 100% for both viruses for simplicity. ␤Gal, ␤-galactosidase. (B) Southern analysis of AdE3ϩ␤Gal and Ad␤Gal/dl1007 DNAs. Total cellular DNA from the liver of a representative injected animal was prepared at 4 or 88 days p.i., digested with NotI, and subjected to Southern analysis (20 g per lane). The radiolabelled probe corresponds to NotI restriction fragments from the AdRSV␤Gal virus, which lacks an internal XbaI fragment within the E3 region (48) . ⌬E1 and ⌬E1⌬E4, TG mice infected with AdE3ϩ ␤Gal and Ad␤Gal/dl1007, respectively. The lane numbering indicates the day of sacrifice p.i. NI, liver of a noninfected transgenic animal. The positions of the 6.4-kb E4 ϩ (AdE3ϩ␤Gal) and 4.5-kb E4 Ϫ (Ad␤Gal/dl1007) NotI restriction fragments are indicated by arrows. These fragments encompass the E3 deletion of the radiolabelled probe, and their signals are less intense than those of the other NotI fragments. The migrations and molecular size of particular fragments from the 1-kb ladder (Gibco BRL) are indicated on the left.
Long-term persistence of the viral DNA in the liver was not associated with a sustained expression of ␤-galactosidase. A similar decline in transgene expression was also noted independently of the extent of the deletion within E4 (Table 2) . Although we cannot formally exclude the possibility that inactivation of E4 resulted in the removal from the viral backbone of cis or trans elements required for long-term gene expression, we favor the hypothesis that rapid extinction of transgene expression from the doubly defective viruses resulted from the use of the RSV LTR to drive its expression. Independent observations actually support the low activity of this promoter in primary hepatocytes in vitro and in vivo (29, 33, 39) . In particular, Overbeek et al. (38) reported that an RSV enhancer/promoter-chloramphenicol acetyltransferase gene construct was functional in many organs but not in the livers of five independent strains of transgenic mice. The RSV LTR contains multiple transcription factor binding sites, including CCAAT/enhancer elements, CArG motifs, and C/EBP binding sites, and it has been previously demonstrated that RSV LTRdriven expression could be induced in vitro by addition of serum and during cellular proliferation (31, 41) . The fact that the E1/E4-defective recombinants in this study did not promote a sustained inflammation or necrosis within the livers of the transgenic mice ( Fig. 9B and C) fits with a progressive downregulation of RSV LTR-driven lacZ expression following infection (Table 2 ). Our observations also imply that administration of either type of virus did initially upregulate the RSV LTR, presumably because of the inflammatory nature of the virus input, leading to similar numbers of X-Gal-positive hepatocytes at 4 days p.i. (Table 2 ). Such an inflammation-induced expression has been previously observed in the livers of mice injected with an E1-deleted recombinant adenovirus whose transgene expression was driven by acute-phase-responsive promoters (51) . During the course of the present study, a paper has appeared in which it was reported that a doubly defective virus, identical to Ad␤Gal/dl1004 except that transgene expression was driven by a composite cytomegalovirus enhancer/␤-actin promoter, was capable of promoting ␤-galactosidase expression for at least 2 months in hepatocytes from ROSA-26 mice with a mixed C57BL/6-129 genetic background (18) . That study and the present study suggest that the additional inactivation of E4 is a prerequisite for stable gene delivery in mouse liver and that the viral backbone is not sequestered in a subcellular compartment that would hamper long-term transgene expression. a Data were determined as described in Table 1 , footnote a. b Doses were 2.5 ϫ 10 9 TDU for AdE3ϩ␤Gal, 4.6 ϫ 10 9 TDU for Ad␤Gal/ dl1007 and Ad␤Gal/dl1004, and 4 ϫ 10 9 TDU for Ad␤Gal/dl1014. c ND, not determined.
